CH4987655
| Code | Size | Price |
|---|
| SYN-1188-M100 | 100 mg | Enquire |
Quantity:
| SYN-1188-M050 | 50 mg | Enquire |
Quantity:
| SYN-1188-M001 | 1 mg | £233.00 |
Quantity:
| SYN-1188-M005 | 5 mg | £590.00 |
Quantity:
| SYN-1188-M010 | 10 mg | £848.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
-20°C
Documents
Further Information
Alternate Names/Synonyms:
RO4987655
Appearance:
Solid.
CAS:
874101-00-5
EClass:
32160000
Form (Short):
liquid
InChi:
InChI=1S/C20H19F3IN3O5/c21-14-9-12(24)3-4-15(14)25-19-13(20(30)26-31-7-5-28)8-11(17(22)18(19)23)10-27-16(29)2-1-6-32-27/h3-4,8-9,25,28H,1-2,5-7,10H2,(H,26,30)
InChiKey:
FIMYFEGKMOCQKT-UHFFFAOYSA-N
Long Description:
Chemical. CAS: 874101-00-5. Formula: C20H19F3IN3O5. MW: 565.3. CH4987655 (RO4987655) is an orally active and highly selective small-molecule MEK inhibitor with an in vitro IC(50) of 5.2nM.
Molecular Formula:
C20H19F3IN3O5
Molecular Weight:
565.3
Package Type:
Plastic Vial
Product Description:
CH4987655 (RO4987655) is an orally active and highly selective small-molecule MEK inhibitor with an in vitro IC(50) of 5.2nM.
Purity:
>95%
Solubility Chemicals:
Soluble in DMSO.
Transportation:
Non-hazardous
UNSPSC Category:
Protein Kinase Modulators
UNSPSC Number:
12352200
Use & Stability:
Stable for at least 2 years after receipt when stored at -20°C.
References
Safety, tolerability, pharmacokinetics and pharmacodynamics following 4 weeks' treatment with empagliflozin once daily in patients with type 2 diabetes: T. Heise, et al.; Diabetes Obes. Metab. 15, 613 (2013)
Related Products
| Product Name | Product Code | Supplier |
|---|